SARS‐CoV‐2 infection may thus be associated with inhibition of Th2‐polarized immune responses and decreased chemotaxis of CRTH2+ cells, thereby promoting the pathophysiology of post‐COVID‐19 pulmonary fibrosis.5 This evidence concerns the gene PTGDR2 and COVID-19.